Financial News
Seres Therapeutics Inc (NQ: MCRB )
0.8707
+0.0107
(+1.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Seres Therapeutics Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/roce_image_548.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2252.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2232.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1085.jpeg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Seres Therapeutics to Present at Chardan Metagenomics and Microbiome Medicines Summit
February 22, 2022
From Seres Therapeutics
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220208005335/en/1351853/4/Seres_Logo_Final.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3171.png)
![](https://mms.businesswire.com/media/20220119005871/en/1332912/4/PRESS_RELEASE_LOGO.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2901.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/dices-over-newspaper-2656028_1920_87.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_340.png)
![](https://g.foolcdn.com/editorial/images/655313/serestherapeutics.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_68.jpg)
![](https://mms.businesswire.com/media/20211130005284/en/931166/4/Seres_Logo_Final.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/roce_image_1419.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_64.jpg)
Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; PubMatic Shares Gain After Q3 Results
November 10, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_4099.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_328.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-morning-market-update_64.jpg)
Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2%
November 10, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_4114.jpeg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20211109006554/en/925389/5/Picture1.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.